Research deepens understanding of malaria parasite
Science carried out in Nottingham helped to form the foundation for the latest breakthrough in the global fight against malaria.
Researchers in the University of Nottingham’s School of Life Sciences were responsible for the identification...
Diagnostic devices reimagined
Diagnostic devices are coming on in leaps and bounds but you may be surprised to learn that one device that’s remained much the same since the late 1950s is the colonoscope. One researcher working...
Know your third party patent rights
In the competitive world of the biosciences, third party patent rights (TPRs) can stand in the way of a planned course of action, even after significant investment has been made. Knowledge of such rights...
Synthetic routes to pharmaceuticals greatly expanded’
Crystallographers provide medicinal chemists with 1,800 additional pharmaceutical building blocks, leading to new and more effective treatments.
A search of the Cambridge Structural Database (CSD) has found nearly 1800 conglomerate crystal structures — molecules that...
Why scientists recommend this type of co-enzyme Q10
Our endogenous Q10 production peaks and starts to decline in our early twenties, however, so many choose to take a supplement to compensate for the age-related loss. In a recent report, Austrian scientists specifically...
Study paves the way for new cirrhosis treatments
The world’s most extensive clinical study into liver cirrhosis has been announced by Newcastle University, University of Edinburgh and r esearch-driven global biopharmaceutical company, Boehringer Ingelheim.
The ADVANCE (Accelerating Discovery: Actionable NASH Cirrhosis Endpoints) study...
Treading the path less travelled – A different approach to patient recruitment
In a previous issue, we spoke to Professor Miles Witham about his work to facilitate the participation of older people in clinical trials. Now we hear from Sarah Montague about a trial engaging homeless...
The IP journey and risk mitigation
Paul Storer
Senior Policy Adviser in the Business Support Policy Team at the IPO
Resolving IP disputes can be costly and the Intellectual Property Office continues to seek to reduce costs for businesses, not only in...
Thriving commercial ecosystems will help universities to keep making an impact beyond Covid-19
Throughout 2020, the life sciences sector has been in the limelight. In the effort to overcome COVID-19, the sector has put into action an unprecedented global application of expertise. The deployment of great minds,...
System could tackle resistant bugs
Once resistant bugs are established in an environment, it can be difficult to eliminate them using ordinary cleaning methods but specialist companies have developed techniques for cleansing an area or individuals.
Rooms and whole departments...
Clinical trials for gene and cell therapies
In early 2020, the Cell and Gene Therapy Catapult (CGTC) reported that there were 127 ongoing trials in advanced therapy medicinal products (ATMP) in the UK. This represented 12 percent of trials globally, helping...
How NHS Wales streamlined sterile manufacturing to increase CCU capacity for second COVID-19 wave
Connect 2 Cleanrooms (C2C) expedited the design and build of a temporary medicines unit for NHS Wales’ new Central Intravenous Additive Service (CIVAS).
In March during the first COVID-19 surge, the UK Government increased Critical...
The Goldilocks Effect
Advances in the delivery of precision medicine trials in the UK have sparked interest in the commercial world.
The concept of precision medicine is not new, but generating the scientific evidence to drive the concept...
The importance of Intellectual Property strategy; creating a foundation on which to build value...
Dr Emma Longland and Craig Thomson
of HGF writing for the Chartered Institute of Patent Attorneys
Most companies in the Biotech space appreciate the need for patent protection; after all, no company wants to bring...
Improved radionuclide supply can transform nuclear medicine
Targeted Alpha Therapy (TAT) is a promising cancer treatment in nuclear medicine, but the supply of alpha-emitting radionuclides - which the treatment relies on - is very limited. A lack of alpha-emitting radionuclides in...
What is Life?
In 1943, the quantum physicist Erwin Schrödinger stood up in Trinity College Dublin and delivered what might be described as the biggest scientific disappointment of the century. His work on quantum mechanics, which so...